01239nas a2200157   4500000000100000008004100001260001500042100001600057700001900073245009100092856007200183300001100255490000700266520079400273022001401067       2023                            d  c2023-08-011 aTiannan Liu1 aEnno Klussmann00aTargeting cAMP signaling compartments in iPSC-derived models of cardiovascular disease  uhttps://www.sciencedirect.com/science/article/pii/S1471489223000474  a1023920 v713 aAdenosine 3′,5′-cyclic monophosphate (cAMP) acts as a second messenger that is involved in the regulation of a plethora of processes. The activation of cAMP signaling in defined compartments is critical for cells to respond to an extracellular stimulus in a specific manner. Rapid advances in the field of human induced pluripotent stem cells (iPSCs) reflect their great potential for cardiovascular disease modeling, drug screening, regenerative and precision medicine. This review discusses cAMP signaling in iPSC-derived cardiovascular disease models, and the prospects of using such systems to elucidate disease mechanisms, drug actions and to identify novel drug targets for the treatment of cardiovascular diseases with unmet medical need, such as hypertension and heart failure.  a1471-4892